Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis

Clinical and Pathophysiological Consequences of Alterations in the Microbiome in Cirrhosis

(2015) Jane Macnaughtan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Infection as a Trigger for Portal Hypertension

(2015) Christian J. Steib et al.   DIGESTIVE DISEASES

Artesunate alleviates hepatic fibrosis induced by multiple pathogenic factors and inflammation through the inhibition of LPS/TLR4/NF-κB signaling pathway in rats

(2015) Lina Lai et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Bacterial Translocation in Alymphoplasia (aly/aly) Mice

(2014) Hodaka Suzuki et al.   FOLIA BIOLOGICA-KRAKOW

Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease

(2014) Prue M. Pereira-Fantini et al.   JOURNAL OF HEPATOLOGY

Alterations of the human gut microbiome in liver cirrhosis

(2014) Nan Qin et al.   NATURE

Risk factors and outcome of bacterial infections in cirrhosis

(2014) Tony Bruns   WORLD JOURNAL OF GASTROENTEROLOGY

Artesunate has its enhancement on antibacterial activity of β-lactams via increasing the antibiotic accumulation within methicillin-resistant Staphylococcus aureus (MRSA)

(2013) Weiwei Jiang et al.   JOURNAL OF ANTIBIOTICS

Microbiota and management of inflammatory bowel disease

(2012) Ian C Lawrance   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Decreased abundance ofFaecalibacterium prausnitziiin the gut microbiota of Crohn's disease

(2012) Takehide Fujimoto et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Regulation of Homeostasis and Inflammation in the Intestine

(2011) Thomas T. MacDonald et al.   GASTROENTEROLOGY

Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense

(2011) Zora Teltschik et al.   HEPATOLOGY

The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine

(2011) Youyou Tu   NATURE MEDICINE

Importance of disrupted intestinal barrier in inflammatory bowel diseases

(2010) Saʼad Y. Salim et al.   INFLAMMATORY BOWEL DISEASES

Regulatory Lymphocytes and Intestinal Inflammation

(2009) Ana Izcue et al.   Annual Review of Immunology

Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell Monolayers

(2009) Luying Peng et al.   JOURNAL OF NUTRITION

Butyrate-Induced Transcriptional Changes in Human Colonic Mucosa

(2009) Steven A. L. W. Vanhoutvin et al.   PLoS One

Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-κB activation

(2008) Bin Li et al.   INTERNATIONAL IMMUNOPHARMACOLOGY